Intractable mental disease clinical classification analysis

OBJECTIVE: To investigate the olanzapine combined with no clinical efficacy in refractory schizophrenia modified electric convulsive therapy : our hospital in July 2006 - May 2009 were treated 60 patients with refractory schizophrenia information, were randomly divided into treatment group (30 cases) and control group (30 cases) and control group were treated with olanzapine treatment, patients taking olanzapine based on the use modified electric convulsive therapy (MECT), continuous treatment 12 weeks, using a positive and negative symptoms rating scale efficacy results in patients with: the difference was statistically significant efficacy in patients (p <0.05) groups had no significant adverse reactions and safe CONCLUSION: MECT combined with olanzapine in the treatment of refractory schizophrenia, clinical results were satisfactory, safe, worthy of promotion.